Login to Your Account

Money, Infrastructure Slow Targeted Drug Use in Chinese Market

By John Fox
Contributing Writer

Wednesday, November 13, 2013

HONG KONG – Hospitals in China are using fewer targeted therapies for lung cancer than their Western counterparts, despite China having the world’s highest number of lung cancer patients and Asians being more susceptible to the disease than Westerners, a leading local oncologist has warned.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription